CHRS - Financial Reports List - Coherus BioSciences, Inc. - IntrinsicAlpha

Coherus BioSciences, Inc. CHRS

Healthcare - Biotechnology - NASDAQ - US

$ 0.8215

5.08 %

$ 95.2 M

Market Cap

3.29

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	-40.84%	36.35%	38.20%
Annual Report	FY	10-K	2024-12-31	3.78%	111.98%	45.05%
Quarterly Report	Q3	8-K	2024-09-30	-5.09%	72.88%	80.04%
Quarterly Report	Q2	8-K	2024-06-30	10.67%	69.86%	40.63%
Quarterly Report	Q1	8-K	2024-03-31	137.58%	237.57%	47.27%
Quarterly Report	Q4	8-K	2023-12-31	101.81%	-20.24%	-32.76%
Annual Report	FY	10-K	2023-12-31	21.89%	27.17%	20.90%
Quarterly Report	Q3	8-K	2023-09-30	64.16%	57.31%	60.22%
Quarterly Report	Q2	8-K	2023-06-30	-2.39%	23.84%	21.52%
Quarterly Report	Q1	8-K	2023-03-31	-46.04%	32.78%	16.29%

1